These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24677183)

  • 1. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
    Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD
    J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.
    Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C
    Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I Signaling in Osterix-Expressing Cells Regulates Secondary Ossification Center Formation, Growth Plate Maturation, and Metaphyseal Formation During Postnatal Bone Development.
    Wang Y; Menendez A; Fong C; ElAlieh HZ; Kubota T; Long R; Bikle DD
    J Bone Miner Res; 2015 Dec; 30(12):2239-48. PubMed ID: 26011431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
    Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J
    Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.
    Meijome TE; Ekwealor JTB; Hooker RA; Cheng YH; Ciovacco WA; Balamohan SM; Srinivasan TL; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
    J Cell Biochem; 2016 Apr; 117(4):959-69. PubMed ID: 26375403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary identification of potential PDZ-domain proteins downstream of ephrin B2 during osteoclast differentiation of RAW264.7 cells.
    Mao Y; Huang X; Zhao J; Gu Z
    Int J Mol Med; 2011 May; 27(5):669-77. PubMed ID: 21373749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification.
    Tonna S; Poulton IJ; Taykar F; Ho PW; Tonkin B; Crimeen-Irwin B; Tatarczuch L; McGregor NE; Mackie EJ; Martin TJ; Sims NA
    Development; 2016 Feb; 143(4):648-57. PubMed ID: 26755702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
    Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
    PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.
    Teramachi J; Nagata Y; Mohammad K; Inagaki Y; Ohata Y; Guise T; Michou L; Brown JP; Windle JJ; Kurihara N; Roodman GD
    J Clin Invest; 2016 Mar; 126(3):1012-22. PubMed ID: 26878170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
    Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
    Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.
    Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z
    Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.
    Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lavigne M; Martel-Pelletier J
    Arthritis Res Ther; 2009; 11(4):R119. PubMed ID: 19664212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
    Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
    Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.
    Kwak H; Salvucci O; Weigert R; Martinez-Torrecuadrada JL; Henkemeyer M; Poulos MG; Butler JM; Tosato G
    J Clin Invest; 2016 Dec; 126(12):4554-4568. PubMed ID: 27820703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
    Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
    Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
    Bhatia S; Sharma J; Bukkapatnam S; Oweida A; Lennon S; Phan A; Milner D; Uyanga N; Jimeno A; Raben D; Somerset H; Heasley L; Karam SD
    Clin Cancer Res; 2018 Sep; 24(18):4539-4550. PubMed ID: 29848571
    [No Abstract]   [Full Text] [Related]  

  • 20. The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo.
    Ge YW; Feng K; Liu XL; Chen HF; Sun ZY; Wang CF; Liu ZQ; Wang HW; Zhang JW; Yu DG; Mao YQ
    Oxid Med Cell Longev; 2020; 2020():1404915. PubMed ID: 32587656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.